Literature DB >> 23439939

Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India.

Neeraj Kabra1, Abhijit Nadkarni.   

Abstract

BACKGROUND: Irritable Bowel Syndrome (IBS) is a very common gastrointestinal dysfunction. Despite strong evidence of high prevalence of depression and anxiety in IBS there is very limited research on this in India.
MATERIALS AND METHODS: Cases of IBS and controls with non-ulcerative dyspepsia were recruited from a gastroenterology clinic in Mumbai, India. Presence of anxiety disorder and depression were assessed by using the Hamilton Anxiety rating scale and Hamilton Depression rating scale respectively. Prevalence rates of anxiety and depression were established and Odds Ratio (OR) was calculated to determine the association of depression and anxiety disorders with IBS.
RESULTS: In IBS cases, the prevalence of depression and anxiety disorder was 37.1% and 31.4% respectively. In patients with IBS the OR for depression was 6.3 (95% CI 1.6-24.74, P=0.009) and the OR for anxiety disorder was 7.56 (95% CI 1.53-37.29, P=0.01).
CONCLUSION: The prevalence of depression and anxiety disorder in IBS is very high. Therefore, screening of IBS patients for anxiety and depression would facilitate better interventions and consequently better outcomes.

Entities:  

Keywords:  Anxiety; depression; irritable bowel syndrome

Year:  2013        PMID: 23439939      PMCID: PMC3574461          DOI: 10.4103/0019-5545.105520

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


INTRODUCTION

Irritable Bowel Syndrome (IBS) is a chronic, continuous or intermittent illness characterized by frequent and unexplained symptoms that include abdominal pain, bloating and bowel disturbance.[1] It is considered to be the most common gastrointestinal (GI) dysfunction[23] with an estimated prevalence of 8-22% in general population.[3-5] It places a heavy burden on health services and accounts for 20-50% of referrals to gastroenterology clinics.[6-8] Though a number of biological triggers have been proposed for onset of IBS,[9-11] it has also been suggested that psychological factors, particularly those associated with the process of somatization play an important role and may even act as markers of IBS onset.[12] Recent studies have shown that subjects with IBS have higher levels of depression, anxiety and neuroticism as compared to those without IBS.[1314] Various studies have shown that as many as 30-40% of patient with IBS have co-morbid depression or anxiety disorder.[1516] It has also been reported that patients who come to medical attention tend to have a greater number of symptoms[17] and are more anxious and depressed.[18] However, most of the evidence on IBS and co-morbid depression or anxiety disorder comes from western studies. There is very little research looking into the prevalence of these psychiatric disorders in patients with IBS in a developing country like India. Given the fact that there are significant socio-cultural differences, it is difficult to generalize research findings from developed countries. It therefore, warrants a need to undertake basic research in a developing country like India. Thus, the aim of this study was to strengthen the limited evidence base by identifying the prevalence of common mental disorders such as depression and anxiety in patients with IBS in an Indian population.

MATERIALS AND METHODS

The sample for this research was selected from the patients attending the gastroenterology out-patient clinic at a government hospital in Mumbai, a metropolitan city of India. Thirty-five patients diagnosed with IBS using Rome's II diagnostic criteria[19] were randomly selected as cases. Another 35 patients diagnosed with non-ulcerative dyspepsia (NUD) from the same clinic were randomly selected as the control group. The only inclusion criterion was that all respondents selected were between the ages of 15 and 65 years. All the selected patients underwent a brief interview for socio-demographic details such as age, gender, employment, education, marital status and socioeconomic status. For the purpose of this analysis, we converted age into a binary variable with a cut-off age of 35 years. Employment status was coded as a binary variable, with those who were currently employed were coded as economically active. Education status was also coded as a binary variable with respondents who were able to read or write were coded as literate. Marital status too was coded as a binary variable with two categories; married and single/post marital (divorced, separated, or widowed). Socio-economic status was determined using the Kuppuswamy's classification. This classification was developed for use in India and has been used extensively in hospital and community based research in India.[2021] This scale takes account of education, occupation and income of the family to classify study groups in to high, middle and low socio-economic status. For our analyses we converted this polychotomous outcome variable into a binary outcome; low socio-economic status and middle/high socio-economic status. Presence of depression was diagnosed using the Hamilton depression rating scale[22] and anxiety disorder was diagnosed using the Hamilton Anxiety rating scale[23] respectively. These rating scales have been used in previous research studies in India.[24]

Analysis

Prevalence of depression and anxiety disorder was calculated for the IBS and control groups. Comparisons were made initially between the socio-demographic characteristics of IBS and control groups using Chi-square tests. In order to determine the independent associations between IBS and depression/anxiety disorders, odds ratios (OR) with 95% confidence intervals were calculated. The threshold for statistical significance was set at the standard P value of 0.05.

RESULTS

In total there were 35 respondents with IBS and 35 controls. The prevalence of depression and anxiety disorder in IBS was 37.1% and 31.4% respectively. The prevalence of depression and anxiety disorder in the control group was 8.6% and 5.7% respectively. Table 1 describes the socio-demographic characteristics of respondents with and without IBS. Compared to the controls, a higher proportion of respondents with IBS were female (45.7% vs. 42.9%), older than 35 years (37.1% vs. 28.6%) and economically inactive (28.6% vs. 17.1%). A significantly higher proportion of respondents with IBS were illiterate (11.4% vs. 0%), single or post-marital (37.1% vs. 11.4%) and were from a lower socio-economic strata (57.1% vs. 25.7%).
Table 1

Prevalence of depression and anxiety in patients with irritable bowel syndrome

Prevalence of depression and anxiety in patients with irritable bowel syndrome The OR for depression in respondents with IBS was 6.3 (95% CI 1.6-24.74, P=0.009). The OR for anxiety disorders in respondents with IBS was 7.56 (95% CI 1.53-37.29, P=0.01)

DISCUSSION

Previous studies from developed countries have reported similar high prevalence rates of anxiety and depression in IBS.[1314] This prevalence of depression or anxiety in IBS is higher than in primary care (16% depression, 24% mixed anxiety depression) population in India[25] and other developing countries (6.2% depression-25% anxiety).[26-28] In a previous study, IBS patients showed an overall higher degree of psychological symptoms in general[29] and anxiety symptoms in particular.[30] In one study the mean scores on Symptom Checking List questionnaire-90 (SCL90) for depression and anxiety in diarrhea predominant IBS (1.1 and 1.0), constipation predominant IBS (1.6 and 1.3), and alternating IBS (1.5 and 1.2) subtypes were higher than in healthy controls (0.4 and 0.4).[29] On the other hand, in a study comparing IBS, Inflammatory bowel disease and chronic hepatitis C (HCV) there was no significant difference between groups in the prevalence of anxiety but IBS group had a statistically significant lower prevalence of depression compared to HCV (15% vs. 34%).[31] Our findings of a high proportion of respondents with IBS (45.7%) than controls (42.9%) being female has also been reported in a previous studies.[3132] In the same studies IBS respondents were significantly older than those with HCV (Mean age 54 vs. 45) which is in accordance with our findings; although in our study this age effect is not statistically significant. The high proportion of economically inactive IBS respondents in our study is in accordance with previous studies which have reported that people with IBS are more likely to be unable to work.[33] Similar to our study findings, Wilson et al. reported a higher risk of IBS in the more deprived but did not report any significant effect of level of education on prevalence of IBS.[34] Although our study has a relatively modest sample size, these are fairly severe cases that were either referred or self-presented to the gastroenterology clinic. Another shortcoming of our study is its cross-sectional design, which does not allow us to determine direction of causality in the relationship between IBS and depression/anxiety. In order to clarify the temporal relationship prospective studies with a bigger sample size are essential in the future. As far as we are aware, this is a first of its kind study in India. Furthermore, we have used standardized and validated rating scales to make a diagnosis of anxiety and depression. The findings of our study can be summarized as follows: (1) IBS is significantly associated with lower education, low socio-economic status and being single or post-marital, (2) Almost a third of the patients with IBS had depression or anxiety disorders, and (3) There is an increased risk of depression and anxiety disorders in IBS as compared to the controls with NUD. IBS accounts for a huge proportion of referrals to gastroenterology clinics and the cost associated with IBS to an individual and to the society are substantial. Psychological disorders comorbid with IBS adds to their disability as well as cost to the individual and the society. Thus, the high prevalence of anxiety and depression in IBS in our study supports a case for screening for these disorders in GI clinics. Furthermore, recognition and treatment of these co-morbidities could improve patient outcomes. Future studies should focus on replicating or refuting these findings in larger samples as well as in testing interventions aimed at targeting psychological morbidities in this patient group.
  30 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 2.  Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials.

Authors:  R B Lydiard; S A Falsetti
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

3.  A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.

Authors:  Y A Saito; G R Locke; N J Talley; A R Zinsmeister; S L Fett; L J Melton
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.

Authors:  Erja Malinen; Teemu Rinttilä; Kajsa Kajander; Jaana Mättö; Anna Kassinen; Lotta Krogius; Maria Saarela; Riitta Korpela; Airi Palva
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

5.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.

Authors:  K R Neal; J Hebden; R Spiller
Journal:  BMJ       Date:  1997-03-15

6.  Poverty, psychological disorder and disability in primary care attenders in Goa, India.

Authors:  V Patel; J Pereira; L Coutinho; R Fernandes; J Fernandes; A Mann
Journal:  Br J Psychiatry       Date:  1998-06       Impact factor: 9.319

7.  Disability associated with mental disorders.

Authors:  Pranit K Chaudhury; Kamala Deka; Dhrubajyoti Chetia
Journal:  Indian J Psychiatry       Date:  2006-04       Impact factor: 1.759

8.  Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers.

Authors:  Elsa M Eriksson; Kristina I Andrén; Henry T Eriksson; Göran K Kurlberg
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

9.  The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.

Authors:  Anjiang Wang; XianHua Liao; LiShou Xiong; Sui Peng; YingLian Xiao; SiChun Liu; PinJin Hu; MinHu Chen
Journal:  BMC Gastroenterol       Date:  2008-09-23       Impact factor: 3.067

10.  Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Jane M Andrews; Nicole T Moulding; Ian G Wilson; Hugh Aj Harley; David J Hetzel; Gerald J Holtmann
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-05-23
View more
  19 in total

1.  Effects of Mastalgia in Young Women on Quality of Life, Depression, and Anxiety Levels.

Authors:  Burhan Hakan Kanat; Murad Atmaca; Mustafa Girgin; Yavuz Selim Ilhan; Ahmet Bozdağ; Zeynep Özkan; Fatih Mehmet Yazar; Seyfi Emir
Journal:  Indian J Surg       Date:  2015-08-28       Impact factor: 0.656

Review 2.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment.

Authors:  Bogdana Ariana Alexandru; Lavinia Alina Rat; Andrada Florina Moldovan; Petru Mihancea; Lavinia Mariș
Journal:  Medicina (Kaunas)       Date:  2022-06-05       Impact factor: 2.948

4.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.

Authors:  Brian E Lacy; William D Chey; Lin Chang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

6.  Acute hepatitis after starting pinaverium bromide in a patient taking mirtazapine.

Authors:  Sandeep Tak; Shubhanjali Tak
Journal:  BMJ Case Rep       Date:  2014-07-11

7.  Irritable bowel syndrome is associated not only with organic but also psychogenic erectile dysfunction.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Int J Impot Res       Date:  2015-10-08       Impact factor: 2.896

8.  Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India - Comments on the article.

Authors:  R Parthasarathy; Vikas Menon
Journal:  Indian J Psychiatry       Date:  2014-10       Impact factor: 1.759

9.  Methylglyoxal induces systemic symptoms of irritable bowel syndrome.

Authors:  Shuang Zhang; Taiwei Jiao; Yushuai Chen; Nan Gao; Lili Zhang; Min Jiang
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

Review 10.  Anxiety and IBS revisited: ten years later.

Authors:  Stefan-Lucian Popa; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.